Jingwen Zhang | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Jingwen Zhang | Medicine and Dentistry | Best Researcher Award

Research Fellow from The University of Melbourne, Australia

Dr. Jingwen Zhang is an emerging epidemiologist specializing in respiratory health, particularly chronic cough in adults. Currently serving as a Research Fellow at the Allergy and Lung Health Unit, The University of Melbourne, she has demonstrated a strong commitment to impactful public health research. With academic training in clinical medicine, public health, and epidemiology, Dr. Zhang brings a unique multidisciplinary perspective to her work. Her research is recognized at both national and international levels, having received prestigious scholarships, competitive grants, and multiple awards for her presentations. She has published extensively and has provided significant contributions as a peer reviewer for leading journals, including The Lancet and New England Journal of Medicine. Beyond her research, Dr. Zhang is actively engaged in teaching, mentoring postgraduate students, organizing scientific meetings, and participating in collaborative initiatives that aim to advance respiratory health research. Her work has attracted considerable media attention, reflecting its relevance to the broader public. Dr. Zhang’s dedication to improving respiratory health outcomes, her leadership in the research community, and her drive for continuous professional development make her a distinguished figure in the field of epidemiology with great potential for future leadership on a global scale.

Professional Profile

Education

Dr. Jingwen Zhang’s academic journey is a blend of excellence in clinical and public health disciplines. She is currently pursuing her Doctor of Philosophy (Epidemiology) at The University of Melbourne, Australia, from 2019 to 2024. Her research focuses on the epidemiology of adult chronic cough, supported by the prestigious University of Melbourne and China Scholarship Council Joint Scholarship. This scholarship covers her tuition fees and provides a substantial living stipend, reflecting the competitiveness of her candidature. Prior to this, she earned a Master of Public Health with First Class Honours from The University of Melbourne in 2018, showcasing her early academic excellence in the public health domain. Her undergraduate degree in Clinical Medicine, obtained from Qingdao University, China, in 2016, provided her with a strong foundation in medical sciences. This diverse educational background equips her with critical clinical insights and advanced epidemiological skills, making her uniquely capable of translating clinical problems into population-based research solutions. Throughout her studies, Dr. Zhang has actively pursued advanced training and upskilling workshops in contemporary epidemiology, clinical trials, and causal inference, further enhancing her scientific competence and professional readiness to address complex public health issues.

Professional Experience

Dr. Jingwen Zhang’s professional journey is marked by progressive research and academic responsibilities. Since 2023, she has been working as a Research Fellow at the Allergy and Lung Health Unit, The University of Melbourne, contributing to cutting-edge respiratory health research. Between 2021 and 2023, she served as a Research Assistant at the same institution, where she supported numerous projects in chronic cough and lung health epidemiology. Her experience extends to academic teaching as a casual tutor at the Centre for Epidemiology and Biostatistics in 2021, where she taught core epidemiology subjects and developed teaching materials for advanced courses. Earlier in her career, in 2016, she worked as a teacher and administrative officer at Amio International Education in China, which provided her with valuable organizational and communication skills. Dr. Zhang’s career also reflects her active participation in scientific committee meetings, leadership in organizing collaborative research initiatives, and volunteer contributions at major scientific conferences. These experiences demonstrate her dedication to academic service and her capacity for multi-tasking across research, teaching, mentoring, and community engagement. Her sustained involvement in both the academic and clinical research environment showcases her readiness to contribute at a higher level within the international research community.

Research Interest

Dr. Jingwen Zhang’s primary research interest lies in the epidemiology of chronic cough and its broader implications for respiratory health. Her doctoral research focuses on understanding chronic cough phenotypes and identifying occupational and environmental risk factors associated with different cough types among middle-aged adults. She is particularly interested in how long-term exposure to air pollution and other environmental factors contribute to chronic respiratory conditions. Her work also explores the epidemiology of asthma-COPD overlap and interventions to improve lung function among adults and children. Dr. Zhang’s research interests extend to the development of evidence-based clinical and public health strategies for improving lung health outcomes. Additionally, she is committed to applying advanced epidemiological methods, including causal inference, longitudinal data analysis, and systematic reviews, to address pressing public health issues. She is passionate about translating complex research findings into actionable insights that can shape policy, clinical practice, and public awareness. Dr. Zhang is also actively involved in collaborative cohort studies such as TAHS and PRECURSOR, which provide large-scale data for respiratory health research. Through her multi-dimensional research focus, Dr. Zhang aims to bridge the gap between clinical observations and population health interventions, ultimately improving respiratory disease management and prevention strategies.

Research Skills

Dr. Jingwen Zhang possesses a diverse and highly applicable skill set that supports her work in epidemiology and respiratory health research. She is proficient in advanced epidemiological study designs, data cleaning, and statistical analysis, with strong expertise in using statistical software such as R and REDCap. Dr. Zhang has completed specialized training in causal inference, clinical trials, reproducible research, and contemporary epidemiology, equipping her with the methodological tools necessary for high-impact research. She has substantial experience in data management, including cleaning and processing large cohort datasets, spirometry data, and address tracking for environmental exposure studies. Dr. Zhang is also skilled in systematic reviews, meta-analyses, and longitudinal study methodologies. Additionally, she has developed teaching skills through her involvement in tutorials, course material development, and student assessment. Dr. Zhang’s experience extends to manuscript preparation, scientific communication, and peer reviewing for high-ranking journals. Her organizational capabilities are evident through her role in coordinating large research initiatives, managing academic social media platforms, and hosting scientific meetings. With strong analytical thinking, attention to detail, and effective communication, Dr. Zhang’s research skills enable her to contribute meaningfully to multidisciplinary teams and deliver impactful epidemiological research outcomes.

Awards and Honors

Throughout her academic and professional journey, Dr. Jingwen Zhang has received several prestigious awards and honors that recognize her contributions to respiratory epidemiology. In 2022, she won the Best Poster Award at the Thoracic Society of Australia and New Zealand Annual Scientific Meeting for her work on occupational risks associated with novel cough phenotypes. In 2023, she received the Golden Prize at the 4th International Cough Conference for her oral presentation on the associations between air pollutants and cough types in middle-aged adults, a recognition that included funding for accommodation and travel. Dr. Zhang was awarded the University of Melbourne and China Scholarship Council Joint Scholarship, a highly competitive program covering both tuition fees and a generous living stipend for her Ph.D. studies. She also secured the PHIRST Grant in 2021 and multiple travel grants in 2024, including the TSANZ Janet Elder International Travel Award. Dr. Zhang’s excellence extends beyond awards, as she has been invited to review manuscripts for leading journals like The Lancet, Thorax, New England Journal of Medicine, and European Respiratory Journal, showcasing her growing influence in the research community. These accolades reflect her scientific rigor, leadership potential, and dedication to improving public health outcomes.

Conclusion

Dr. Jingwen Zhang exemplifies the qualities of an outstanding early-career researcher with a promising future in the field of epidemiology and respiratory health. Her strong academic foundation, research productivity, and active participation in academic service position her as a rising leader in public health research. Dr. Zhang’s work addresses a critical gap in chronic cough epidemiology and contributes valuable knowledge with the potential to influence clinical guidelines and public health policies. She has successfully combined rigorous research with impactful community engagement and international scientific dissemination. Her role as a mentor and organizer further demonstrates her leadership and commitment to building collaborative research environments. With further opportunities to expand international collaborations, increase first-author publications in top-tier journals, and lead larger research grants, Dr. Zhang is well-positioned to achieve global recognition in her field. Her comprehensive skill set, exceptional dedication, and passion for improving respiratory health outcomes make her a highly deserving candidate for prestigious research awards and continued academic advancement. Dr. Zhang’s career trajectory reflects not only her scientific excellence but also her potential to drive meaningful change in public health both nationally and internationally.

Publications Top Notes

1. Associations Between Occupational Exposures and Cough Subclasses Among Middle‐Aged Australians

  • Authors: Jingwen Zhang, Jennifer L. Perret, Dinh S. Bui, Sheikh M. Alif, Michael J. Abramson, Anne B. Chang, Hans Kromhout, Garun S. Hamilton, Paul S. Thomas, Bircan Erbas, et al.

  • Year: 2025

2. Chronic Bronchitis in Children and Adults: Definitions, Pathophysiology, Prevalence, Risk Factors, and Consequences

  • Authors: Jingwen Zhang, Danielle F. Wurzel, Jennifer L. Perret, Caroline J. Lodge, E. Haydn Walters, Shyamali C. Dharmage

  • Year: 2024

3. Association of Novel Adult Cough Subclasses With Clinical Characteristics and Lung Function Across Six Decades of Life in a Prospective, Community-Based Cohort in Australia: An Analysis of the Tasmanian Longitudinal Health Study (TAHS)

  • Authors: Jingwen Zhang, Caroline J. Lodge, E. Haydn Walters, Anne B. Chang, Dinh S. Bui, Adrian J. Lowe, Garun S. Hamilton, Paul S. Thomas, Chamara V. Senaratna, Alan L. James, et al.

  • Year: 2024

4. A Review of the Role of Pollen in COVID-19 Infection

  • Authors: Nur Sabrina Idrose, Jingwen Zhang, Caroline J. Lodge, Bircan Erbas, Jo A. Douglass, Dinh S. Bui, Shyamali C. Dharmage

  • Year: 2023

5. Risk Factors for Chronic Cough in Adults: A Systematic Review and Meta‐Analysis

  • Authors: Jingwen Zhang, Jennifer L. Perret, Anne B. Chang, Nur S. Idrose, Dinh S. Bui, Adrian J. Lowe, Michael J. Abramson, E. Haydn Walters, Caroline J. Lodge, Shyamali C. Dharmage

  • Year: 2022

6. Serum Cytokine Concentrations and Asthma Persistence to Middle Age

  • Authors: Jingwen Zhang, Eugene H. Walters, Mimi L. K. Tang, Adrian J. Lowe, Caroline J. Lodge, Dinh Bui, Rangi Kandane‐Rathnayake, Bircan Erbas, Garun S. Hamilton, Bruce R. Thompson, et al.

  • Year: 2020

Hui-Qiang Wei | Medicine and Dentistry | Young Researcher Award

Posted on by Shen Awards

Dr. Hui-Qiang Wei | Medicine and Dentistry | Young Researcher Award

Guangdong Cardiovascular Institute, China

Dr. Hui-Qiang Wei is a dedicated clinical researcher and medical doctor specializing in cardiac electrophysiology. Currently affiliated with the Arrhythmia Center at the Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital, and Southern Medical University in Guangzhou, China, Dr. Wei has built a focused and impactful career in the management and ablation of complex cardiac arrhythmias. Born in June 1990, he has steadily advanced through rigorous academic and clinical training in cardiology, with specific attention to electrophysiological interventions. Dr. Wei’s work spans both academic research and clinical practice, with a strong emphasis on catheter ablation techniques, including those involving atrial fibrillation, supraventricular tachycardias, and ventricular arrhythmias. He has contributed to multiple peer-reviewed publications in high-impact journals, and his findings have improved the understanding and procedural outcomes of cryoballoon and substrate-based ablation methods. Additionally, Dr. Wei has engaged in international collaboration through observership at the University of Pennsylvania, further enriching his perspective and methodology. His dedication to electrophysiology, growing publication record, and translational clinical research make him an emerging leader in the field. With both depth and breadth of experience, Dr. Wei exemplifies the qualities of a promising young researcher and is well-suited for consideration in prestigious research awards.

Professional Profile

Education

Dr. Hui-Qiang Wei’s educational background is firmly rooted in the cardiovascular sciences, with a particular focus on electrophysiology. He began his medical education at Southern Medical University in Guangzhou, China, where he earned his M.D. in 2013. Demonstrating an early interest in cardiology, he continued with a Master’s degree in Electrophysiology from the Guangdong Cardiovascular Institute under the mentorship of Professor Silin Chen, completing the program in 2016. Furthering his specialization, Dr. Wei pursued his Ph.D. at Fuwai Hospital, a premier cardiovascular center in Beijing, under the guidance of Professor Jian Ma. He completed his doctoral degree in 2019, focusing on advanced electrophysiological diagnostics and interventions. His academic journey has been marked by consistency, a commitment to specialization, and mentorship under leading figures in Chinese cardiovascular medicine. Additionally, he broadened his academic exposure with a visiting observership at the Hospital of the University of Pennsylvania in 2018, where he gained valuable insights into global standards in arrhythmia management and research methodology. Dr. Wei’s education has provided him with a strong theoretical foundation, clinical training, and exposure to both national and international best practices in cardiac electrophysiology.

Professional Experience

Dr. Hui-Qiang Wei has cultivated a professional career that seamlessly integrates clinical excellence with high-quality research in cardiac electrophysiology. Since 2019, he has been a part of the Guangdong Cardiovascular Institute at Guangdong Provincial People’s Hospital, a prominent center for cardiovascular care and research. In his current role at the Arrhythmia Center, he is actively engaged in both clinical procedures and research initiatives, particularly focusing on catheter-based interventions for complex arrhythmias. Prior to this position, he completed significant training and clinical work during his master’s and doctoral programs, contributing to studies in ablation therapy under the mentorship of renowned electrophysiologists. His brief but impactful time as a visiting observer at the Hospital of the University of Pennsylvania in 2018 allowed him to observe state-of-the-art procedures and academic protocols at a world-class institution. Throughout his career, Dr. Wei has performed numerous complex arrhythmia interventions and has collaborated on multi-center studies examining the efficacy and safety of various ablation technologies. His practical experience has been reinforced by continuous involvement in academic writing and presentations, bridging the gap between clinical innovation and scholarly contribution. This dual focus on practice and research underscores his professional strength and growth trajectory in cardiac electrophysiology.

Research Interest

Dr. Hui-Qiang Wei’s primary research interest lies in the field of cardiac electrophysiology, with a specialized focus on the diagnosis and interventional management of complex cardiac arrhythmias. His research has primarily explored catheter ablation techniques, including pulmonary vein isolation, ventricular tachycardia ablation, and the use of cryoballoon ablation in varied anatomical and clinical contexts. Dr. Wei is particularly interested in understanding the electrophysiological characteristics of arrhythmogenic substrates and developing strategies to improve the precision and safety of ablation therapies. His work investigates both traditional and emerging technologies, such as second-generation cryoballoon catheters, and their application in clinical and experimental settings. Additionally, he has contributed to comparative studies assessing different ablation strategies for left posterior fascicular ventricular tachycardia, and has examined long-term outcomes in substrate-based interventions. The translational nature of his research—applying physiological insights to improve procedural outcomes—marks a significant contribution to the field. Dr. Wei’s continued interest in refining ablation protocols and identifying predictors of arrhythmia recurrence aligns with global efforts to enhance the effectiveness of interventional electrophysiology and reduce procedural risks for patients.

Research Skills

Dr. Hui-Qiang Wei possesses a wide range of research skills that support his work as a clinical scientist in the domain of cardiac electrophysiology. He is proficient in designing and executing both clinical and experimental studies, including prospective and retrospective data analyses focused on catheter ablation outcomes. His experience includes electrophysiological mapping, real-time potential recording, and advanced imaging techniques used to guide and evaluate ablation procedures. Dr. Wei has also demonstrated competence in using animal models to investigate the safety and efficacy of ablation tools, as evidenced by his co-authored study on cryoballoon ablation in a canine model. His familiarity with statistical analysis and medical software allows him to handle complex datasets, ensuring the reliability and validity of his findings. Furthermore, his involvement in multi-center studies and collaborations with prominent researchers, such as Dr. Jian Ma and Dr. Jackson J. Liang, reflects his ability to work within diverse research teams. Dr. Wei is adept at translating clinical observations into research hypotheses and subsequently testing them through structured protocols. His clear scientific writing, ability to present findings at international conferences, and continuous engagement in peer-reviewed publication demonstrate strong communication and dissemination skills essential for academic medicine.

Awards and Honors

While no specific individual awards have been listed in the provided data, Dr. Hui-Qiang Wei’s professional trajectory reflects recognition through academic appointments, publication credits, and invited presentations that signal growing acknowledgment within the scientific and clinical community. Notably, he was selected for an oral presentation at the Asia Pacific Heart Rhythm Society (APHRS) 2017 conference, which is a respected forum for cardiac electrophysiologists in the Asia-Pacific region. His collaborative work has been published in leading cardiology journals such as Heart Rhythm, Europace, and Journal of Cardiovascular Electrophysiology, indicating the high quality and relevance of his research. Being first author or co-author on such impactful studies suggests trust and esteem from his mentors and research collaborators. His visiting observer role at the Hospital of the University of Pennsylvania also highlights academic merit, as such opportunities are typically offered to promising researchers with demonstrable academic potential. Although explicit awards or honors are not detailed, Dr. Wei’s academic output and the caliber of his institutional affiliations imply ongoing professional recognition and the potential for future accolades in his field.

Conclusion

Dr. Hui-Qiang Wei exemplifies the qualities of a dedicated and capable young researcher whose contributions to cardiac electrophysiology are both meaningful and steadily expanding. His focused academic background, hands-on clinical experience, and a growing portfolio of peer-reviewed publications position him as an emerging leader in arrhythmia research and intervention. He demonstrates a clear understanding of current challenges in the field and actively works toward improving procedural safety and efficacy through data-driven methods. His commitment to both research and patient care, reinforced by international exposure and collaboration, reflects a balanced professional maturity that is commendable for a researcher of his career stage. With continued development in research leadership, grant participation, and broader dissemination of his work, Dr. Wei is likely to make substantial long-term contributions to cardiovascular medicine. His background, experience, and vision align well with the purpose of the Young Researcher Award, making him a strong candidate deserving of recognition. As he continues to evolve in his academic and clinical endeavors, Dr. Wei is poised to become an influential figure in advancing electrophysiological practice and research both in China and internationally.

Publication Top Notes

  1. Association between age at diagnosis of atrial fibrillation and subsequent risk of ischemic stroke
    Authors: Y. Cheng, H. Deng, H. Wei, Y. Xue, Z. Wu
    Journal: Journal of the American Heart Association
    Year: 2025

  2. A giant left atrial appendage aneurysm with incessant atrial tachycardia
    Authors: H. Wei, Y. Xue, S. Wu, H. Liao
    Journal: Journal of Cardiovascular Electrophysiology
    Year: 2025

  3. A novel mutation in hERG gene associated with azithromycin-induced acquired long QT syndrome
    Authors: Y. Cheng, Y. Wu, H. Wei, L. Liu, W. Bi
    Journal: Molecular Biology Reports
    Year: 2024
    Citations: 1

 

Saverio Cinti | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Prof. Dr. Saverio Cinti | Medicine and Dentistry | Best Researcher Award

Scientific Director of the Obesity Center of the Polytechnic University of Marche from Polytechnic University of Marche, Italy

Prof. Saverio Cinti is a distinguished researcher and academic in the field of obesity, adipose tissue physiology, and human anatomy. With over 35 years of experience in medical research and education, he has made groundbreaking contributions to the understanding of fat biology, metabolism, and obesity-related disorders. He has served as a Full Professor of Human Anatomy at Marche Polytechnic University and is currently the Scientific Director of the Obesity Center at the same institution. His prolific research output includes over 340 peer-reviewed publications, with an impressive H-index of 87 and 37,585 citations (Scopus), demonstrating his global influence in the scientific community. He has also authored books, contributed to over 20 book chapters, and holds multiple patents in the field of metabolic diseases. Prof. Cinti has been an invited speaker at prestigious institutions, including Harvard, Columbia, NIH, and the European Congress of Endocrinology. His contributions have been recognized with prestigious awards, such as the Blaise Pascal Medal and the Friedrich Wassermann Prize. As a pioneer in adipose tissue research, his work continues to shape the future of obesity treatment and metabolic health on an international scale.

Professional Profile

Education

Prof. Saverio Cinti’s academic journey began with a Doctor of Medicine (MD) degree from the University of Padua in 1974. He then pursued specialization in Internal Medicine at the University of Verona (1979) and Surgical Pathology at the University of Milan (1982). His advanced training provided him with a strong foundation in human anatomy, cellular biology, and pathology, which later became central to his research on obesity and adipose tissue. Over the years, he has continuously expanded his expertise, engaging in multidisciplinary medical research and international collaborations. His education has been complemented by extensive teaching experience, particularly in anatomy, histology, and obesity-related metabolic studies. His deep understanding of human anatomy and pathology has allowed him to bridge the gap between basic research and clinical applications. His affiliation with global institutions, including the University of Copenhagen and the University of Bonn, further highlights his role as a leading educator and researcher in the field. His academic background, combined with his dedication to continuous learning, has positioned him as a key figure in obesity and metabolic disorder research.

Professional Experience

Prof. Cinti has held several prominent academic and research positions over the past four decades. From 1984 to 2020, he was the Head of the Anatomy and Cell Biology Unit at the Department of Experimental and Clinical Medicine at Marche Polytechnic University. He served as a Full Professor of Human Anatomy from 1986 to 2020, where he played a crucial role in shaping medical education. His leadership extends beyond academia, as he has also been the Director of the Obesity Center at Marche Polytechnic University since 2011 and the Scientific Director of the Obesity Center since 2020. His international experience includes being an Affiliated Professor at the University of Copenhagen and a Distinguished Professor Emeritus at the University of Bonn. Additionally, he has served as the President of the Italian Society of Obesity (SIO) from 2008 to 2010. His long-standing involvement in clinical research and academic leadership has significantly contributed to advancements in obesity and adipose tissue research. His career is marked by extensive grant funding (~€2.5 million), numerous high-impact publications, and collaborative efforts in obesity and metabolic disease research.

Research Interest

Prof. Cinti’s research primarily focuses on adipose tissue biology, obesity mechanisms, and metabolic disorders. His work has provided crucial insights into the function, differentiation, and plasticity of adipocytes, particularly in relation to metabolic diseases such as diabetes and obesity. He has extensively studied the role of white, brown, and beige adipose tissue in energy metabolism and thermogenesis. His research also explores the cellular and molecular mechanisms of fat storage, lipid metabolism, and the impact of obesity on systemic health. A key aspect of his work involves understanding how adipose tissue dysfunction contributes to metabolic syndrome, cardiovascular diseases, and inflammation-related disorders. He has been actively involved in translational research, bridging laboratory discoveries with potential clinical applications for obesity treatment. His studies on leptin, irisin, and adipose-derived stem cells have contributed to the development of innovative therapies for metabolic diseases. Additionally, his research extends to regenerative medicine, focusing on adipose tissue engineering for tissue repair and renewal. His contributions continue to shape obesity research, paving the way for novel therapeutic approaches and a better understanding of adipose tissue biology.

Research Skills

Prof. Cinti possesses a diverse range of research skills, making him a leading authority in obesity and adipose tissue studies. He is highly skilled in electron microscopy, histological analysis, and molecular biology techniques, which he has used to investigate the structure and function of adipose tissues. His expertise in cellular and molecular biology has allowed him to make groundbreaking discoveries regarding adipocyte differentiation and metabolic regulation. He is proficient in animal models of obesity, metabolic syndrome, and diabetes, enabling him to conduct preclinical research on obesity treatments. His work also involves biochemical assays, gene expression analysis, and imaging techniques to study fat metabolism and energy homeostasis. Additionally, he has experience in clinical research methodologies, including patient-based studies on obesity, metabolic disorders, and regenerative medicine. His strong background in scientific writing and peer reviewing has led to contributions in top-tier journals such as Nature, Science, and Cell Metabolism. His ability to integrate basic science with clinical applications has made him a pioneer in translational obesity research.

Awards and Honors

Prof. Cinti has received numerous prestigious awards in recognition of his contributions to obesity research. In 2008, he was awarded the Blaise Pascal Medal by the European Academy of Science, a prestigious honor for his pioneering work in metabolic diseases. In 2013, he received the Friedrich Wassermann Prize from the European Association for the Study of Obesity (EASO), further highlighting his impact on obesity research. He has also been honored as a Distinguished Professor Emeritus at the University of Bonn and has been a plenary speaker at international conferences, including Harvard, Columbia University, and the European Congress of Endocrinology. He has served as a peer reviewer for leading journals such as Science, Nature, and Cell Metabolism, further cementing his reputation as a global expert in obesity and metabolic disorders. His extensive contributions have also been recognized through significant research funding (~€2.5 million over the last decade) and multiple patents related to obesity treatment and metabolic health. These awards and honors reflect his exceptional influence in the scientific community.

Conclusion

Prof. Saverio Cinti is an internationally renowned researcher whose groundbreaking work in obesity and adipose tissue biology has significantly advanced the field. With an illustrious career spanning over four decades, he has contributed extensively through research, education, and leadership roles. His vast publication record, high citation impact, and numerous awards showcase his global influence. His research has led to new insights into fat metabolism, obesity treatment, and regenerative medicine, positioning him at the forefront of translational obesity research. His commitment to scientific excellence, combined with his mentorship and leadership roles, has inspired countless researchers worldwide. Moving forward, expanding interdisciplinary collaborations, integrating emerging technologies, and increasing public outreach could further enhance his already significant impact. Prof. Cinti’s contributions make him a strong candidate for the Best Researcher Award, reflecting his exceptional dedication to scientific progress and medical innovation.

Publications Top Notes

  • Title: A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
    Authors: P. Boström, J. Wu, M.P. Jedrychowski, A. Korde, L. Ye, J.C. Lo, K.A. Rasbach, …
    Year: 2012
    Citations: 5879

  • Title: Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1
    Authors: Z. Wu, P. Puigserver, U. Andersson, C. Zhang, G. Adelmant, V. Mootha, …
    Year: 1999
    Citations: 4936

  • Title: Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans
    Authors: S. Cinti, G. Mitchell, G. Barbatelli, I. Murano, E. Ceresi, E. Faloia, S. Wang, …
    Year: 2005
    Citations: 3248

  • Title: Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss
    Authors: R. Cancello, C. Henegar, N. Viguerie, S. Taleb, C. Poitou, C. Rouault, …
    Year: 2005
    Citations: 1498

  • Title: Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice
    Authors: P. Seale, H.M. Conroe, J. Estall, S. Kajimura, A. Frontini, J. Ishibashi, P. Cohen, …
    Year: 2011
    Citations: 1482

  • Title: Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1α null mice
    Authors: J. Lin, P.H. Wu, P.T. Tarr, K.S. Lindenberg, J. St-Pierre, C. Zhang, V.K. Mootha, …
    Year: 2004
    Citations: 1465

  • Title: The adipose organ
    Authors: S. Cinti
    Year: 2007
    Citations: 1161

  • Title: βAR signaling required for diet-induced thermogenesis and obesity resistance
    Authors: E.S. Bachman, H. Dhillon, C.Y. Zhang, S. Cinti, A.C. Bianco, B.K. Kobilka, …
    Year: 2002
    Citations: 1079

  • Title: Ablation of PRDM16 and beige adipose causes metabolic dysfunction and a subcutaneous to visceral fat switch
    Authors: P. Cohen, J.D. Levy, Y. Zhang, A. Frontini, D.P. Kolodin, K.J. Svensson, J.C. Lo, …
    Year: 2014
    Citations: 967

  • Title: The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation
    Authors: G. Barbatelli, I. Murano, L. Madsen, Q. Hao, M. Jimenez, K. Kristiansen, …
    Year: 2010
    Citations: 948

  • Title: The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue
    Authors: M.C. Zingaretti, F. Crosta, A. Vitali, M. Guerrieri, A. Frontini, B. Cannon, …
    Year: 2009
    Citations: 915

  • Title: Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice
    Authors: I. Murano, G. Barbatelli, V. Parisani, C. Latini, G. Muzzonigro, M. Castellucci, …
    Year: 2008
    Citations: 879

 

Rajesh Kanna Gopal | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Assist. Prof. Dr. Rajesh Kanna Gopal | Medicine and Dentistry | Best Researcher Award

Assistant Professor at Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, India

Dr. Rajesh Kanna G. is a dedicated researcher with a strong background in Phycotechnology (Algal Biotechnology). With over nine years of experience, he has made significant contributions to the fields of anticancer and antiviral bioactive compounds, phycoremediation, bioplastics, and livestock feed derived from algae. As an Assistant Professor in the Department of Microbiology at Saveetha Dental College and Hospitals, Chennai, Dr. Kanna has consistently demonstrated his passion for advancing knowledge in plant biology and biotechnology. His establishment of the Centre for Phycotechnology at Saveetha Institute of Medical and Technical Sciences (SIMATS) further showcases his commitment to fostering research in algae-based biotechnologies. With numerous publications, a growing citation record, and an expanding research portfolio, he is a respected name in his field.

Professional Profile

Education:

Dr. Rajesh Kanna G. completed his Ph.D. in Plant Biology and Plant Biotechnology from the University of Madras, Chennai, where his thesis focused on the isolation, purification, and characterization of superoxide dismutase (SOD) enzymes from microalgae. He holds an M.Phil. in Botany, focusing on cholesterol oxidase production from Stenotrophomonas sp. Additionally, Dr. Kanna earned his M.Sc. and B.Sc. in Plant Biology and Biotechnology from the University of Madras, where he graduated with top honors, securing first place in his M.Sc. class.

Professional Experience:

Dr. Kanna’s professional journey spans multiple academic and research roles. He is currently serving as an Assistant Professor in the Department of Microbiology at Saveetha Dental College and Hospitals, Chennai. His previous roles include Project Assistant at the NEERI-CSIR Chennai Zonal Laboratory, where he contributed to soil remediation trials at a mercury-contaminated site, and Junior Research Fellow at Presidency College, where he isolated a novel strain of Botryococcus braunii for biofuel production. His experience in both academic and applied research has shaped his approach to solving complex environmental and health-related challenges.

Research Interests:

Dr. Rajesh Kanna’s research interests lie primarily in the application of Phycotechnology, focusing on the potential of macro and microalgae for bioactive compound production, including anticancer and antiviral substances. His work also includes phycoremediation, the use of algae to degrade pollutants, and the development of algae-based biotechnologies for applications in livestock feed, hydroxyapatite production, bioplastics, and antimicrobial peptides. His multidisciplinary research is aimed at advancing sustainable, eco-friendly solutions to pressing environmental and health issues.

Research Skills:

Dr. Kanna possesses a wide range of technical skills that support his diverse research in Phycotechnology. These include expertise in microalgae isolation and cultivation, including raceway pond systems and photobioreactor cultivation. He is proficient in a variety of molecular techniques, enabling him to analyze and manipulate algae at the genetic and biochemical levels. His experience also spans biotechnological applications such as biofuel production, bioplastics, antimicrobial peptide synthesis, and phycoremediation. Dr. Kanna is skilled in leading laboratory teams and projects, fostering innovation in algae-based research.

Awards and Honors:

Dr. Rajesh Kanna G. has received numerous accolades for his academic and research achievements. He was honored with the Young Scientist Award at SRM-ICBEST’22, recognizing his exceptional contributions to the field of Phycotechnology. He has also earned multiple academic distinctions, including securing First Rank in his M.Sc. and receiving various endowment prizes from the University of Madras and his college. These honors reflect his commitment to academic excellence and his growing reputation in the field of plant biotechnology and Phycotechnology.

Conclusion:

Dr. Rajesh Kanna G. is highly deserving of recognition as a Best Researcher due to his exceptional research in Phycotechnology, his contributions to sustainable biotechnology, and his successful track record of academic excellence and innovation. His research not only addresses pressing environmental issues but also presents solutions with broad potential for industrial applications. While there is room to expand his collaborative efforts and visibility, his consistent research output, leadership in establishing a research center, and recognition through awards make him an outstanding candidate for this award.

Publication Top Notes:

  1. Biodegradation of polyethylene by green photosynthetic microalgae
    Authors: RV Kumar, GR Kanna, S Elumalai
    Journal: J Bioremediat Biodegrad 8 (381), 2
    Year: 2017
    Citation: 177
  2. Biodegradation of low-density polyethylene (LDPE) sheet by microalga, Uronema africanum Borge
    Authors: E Sanniyasi, RK Gopal, DK Gunasekar, PP Raj
    Journal: Scientific Reports 11 (1), 17233
    Year: 2021
    Citation: 76
  3. In vitro anti-HIV-1 activity of the bioactive compound extracted and purified from two different marine macroalgae (seaweeds) (Dictyota bartayesiana JV Lamouroux and Turbinaria…)
    Authors: E Sanniyasi, G Venkatasubramanian, MM Anbalagan, PP Raj, RK Gopal
    Journal: Scientific Reports 9 (1), 12185
    Year: 2019
    Citation: 55
  4. Retrospective and prospective application of robots and artificial intelligence in global pandemic and epidemic diseases
    Authors: A Yoganandhan, GR Kanna, SD Subhash, JH Jothi
    Journal: Vacunas (English Edition) 22 (2), 98-105
    Year: 2021
    Citation: 25
  5. Industrial production of Superoxide Dismutase (SOD): A mini review
    Authors: RK Gopal, S Elumalai
    Journal: J. Probiotics Health 5 (5)
    Year: 2017
    Citation: 18
  6. In vitro anticancer potential of laminarin and fucoidan from Brown seaweeds
    Authors: E Sanniyasi, RK Gopal, R Damodharan, A Arumugam, M Sampath Kumar, …
    Journal: Scientific Reports 13 (1), 14452
    Year: 2023
    Citation: 16
  7. Extraction of carotenoid and thin layer chromatography (TLC), GC-MS, FT-IR and HPLC analysis of pharmaceutically important pigment astaxanthin from a new strain of…
    Authors: S Elumalai, BI Santhose, GR Kanna
    Journal: Weekly Science Research Journal 2 (8), 2321-7871
    Year: 2014
    Citation: 16
  8. Characterization and in vitro anticancer potential of exopolysaccharide extracted from a freshwater diatom Nitzschia palea (Kütz.) W.Sm. 1856
    Authors: RKGRD Elumalai Sanniyasi, Antony Prakash Rejoy Patrick, Kreedika Rajagopalan
    Journal: Scientific Reports 12, 22114
    Year: 2022
    Citation: 11
  9. Synthesis of bioethanol by dark fermentation using marine seaweed Acanthophora spicifera (Vahl.) Borgesen as a cheap substrate
    Authors: A Umamaheswari, P Saranraj, G Rajesh Kanna, S Elumalai, T Sangeetha
    Journal: Bioenergetics 6 (146), 2
    Year: 2017
    Citation: 7
  10. Extraction of phycocyanin an important pharmaceutical phycobiliproteins from cyanobacteria
    Authors: S Elumalai, KG Rajesh, G Jegan, T Sangeetha, SD Roop
    Journal: Int J Pharmaceut Res Dev 6, 67-74
    Year: 2014
    Citation: 7

 

Vaibhav Sharma | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Vaibhav Sharma | Medicine and Dentistry | Best Researcher Award

Clinical Observer at St. Louis Heart and Vascular, St. Louis, MO, United States

Vaibhav Sharma is a dedicated medical graduate with a strong foundation in clinical practice and research. With two years of patient care experience, he has developed a keen eye for detailed medical assessments and accurate documentation. His leadership in innovative health screening projects demonstrates his commitment to improving healthcare outcomes. Vaibhav is passionate about advancing medicine through evidence-based practices and interdisciplinary collaboration, combining his expertise in patient care with a drive for continuous learning and research. Aspiring to a respected academic position, he seeks to contribute to healthcare advancement through impactful research and clinical practice, aiming to make a meaningful difference in patient care and medical progress.

Professional Profile

Education

Vaibhav Sharma completed his MBBS from the Armed Forces Medical College (AFMC), Pune, India, from August 2017 to February 2024. He consistently ranked among the top 10% of his class, excelling in subjects like Pharmacology, Microbiology, Ophthalmology, Otorhinolaryngology, and Pediatrics. He has successfully passed USMLE Step 1 and Step 2 CK, achieving a high score of 271 in Step 2 CK, placing him in the 98th percentile. He also holds impressive scores in the TOEFL (115/120) and the Occupational English Test, showcasing his strong command over the English language. His academic background is marked by a solid blend of clinical skills and theoretical knowledge, laying a strong foundation for his future endeavors in the medical field.

Professional Experience

Vaibhav Sharma’s professional journey includes a Visiting Scholar role at the University of Texas Health in Houston, where he immersed himself in advanced heart failure and heart transplant care. His experience extends to an observership at Christian Hospital in St. Louis, Missouri, where he enhanced his understanding of interventional cardiology and electrophysiology. Prior to this, he completed an externship at the Heart and Vascular Institute in Detroit, Michigan, focusing on cardiovascular health management and patient care efficiency. He also served as a Research Analyst at Panscience Innovations, where he led the development of an AI-based software aimed at improving clinical operations. Vaibhav’s clinical internship at Command Hospital, Pune, provided hands-on experience across various specialties, allowing him to contribute to rural health screening projects and develop efficient screening interventions for lifestyle diseases.

Research Interest

Vaibhav Sharma’s research interests lie at the intersection of clinical medicine and innovative health technologies. He is passionate about exploring cardiovascular diseases, particularly focusing on heart failure, arrhythmias, and myocardial conditions. His projects have included screening interventions for hematological abnormalities and lifestyle diseases in rural populations, emphasizing early detection and preventive care. Vaibhav is also interested in the role of lipid profiles in the progression of diabetic retinopathy, as well as the genetic basis of stress-induced ventricular arrhythmias. He aims to integrate emerging technologies, such as AI and machine learning, into clinical research to enhance diagnostic accuracy and treatment outcomes. His research reflects a commitment to advancing evidence-based practices and improving patient care through rigorous scientific inquiry.

Research Skills

Vaibhav Sharma possesses a robust set of research skills that enable him to conduct thorough and impactful studies. He is proficient in designing and executing clinical surveys, as demonstrated in his rural welfare research on myeloma screening and lifestyle disease prevention. His experience includes data collection, statistical analysis, and interpretation of complex clinical data, skills that he has applied in projects such as his lipid profile study on diabetic retinopathy patients. Vaibhav is also skilled in using electronic medical record (EMR) systems like EPIC for research purposes, ensuring accurate data management. Additionally, he has a strong background in preparing manuscripts for publication, contributing to peer-reviewed journals. His ability to collaborate with multidisciplinary teams and present research findings effectively makes him a valuable contributor to the scientific community.

Awards and Honors

Vaibhav Sharma has earned several awards and recognitions throughout his academic and professional journey. He received a prestigious research grant from the Indian Council of Medical Research (ICMR) for his study on the lipid profile in diabetic retinopathy patients. He was also acknowledged by the state government for his rural welfare project, which received a “Mega Project” status and a sponsorship of INR 1,00,00,000. In addition, Vaibhav has been recognized for his academic excellence, consistently ranking in the top 10% of his class at AFMC, Pune, and securing honors in multiple medical disciplines. He has also received accolades for his contributions to clinical presentations, such as his case presentation on bisalbuminemia at the American College of Physicians – India Chapter. His achievements reflect his dedication to medical research, academic excellence, and community-focused healthcare initiatives.

Conclusion

Vaibhav Sharma is a promising candidate for the Best Researcher Award, with strengths in conducting impactful research, receiving grants, and integrating clinical experience with research insights. His strong academic background and contributions to the field of cardiology and community health research are commendable. By focusing on long-term studies, enhancing his publication record, and narrowing his research focus, he can further strengthen his candidacy. His passion for continuous learning and medical advancement makes him a valuable asset to the research community.

Publications Top Notes

  1. SAICR‐CTO: Single Access Impella‐Guided Complete Revascularization in Chronic Total Occlusion—A Novel Approach to High‐Risk PCI
    • Journal: Catheterization and Cardiovascular Interventions
    • Year: 2024-10-22
    • DOI: 10.1002/ccd.31277
    • Contributors: Vaibhav Sharma, Abishek Arokiadoss, Anjali Bhardwaj, Shariq Shamim
  2. Comparison between Amino Acid Profiling of Structural Proteins of Earliest and Recent Omicron Strain of SARS-CoV-2 and Nutritional Burden on COVID-19 Patients
    • Journal: Human Nutrition & Metabolism
    • Year: 2023-12
    • DOI: 10.1016/j.hnm.2023.200220
    • Contributors: Vivek Ambade, Sonia Ambade, Vaibhav Sharma, Prasanna Sanas
  3. Normative Data of Beta-2-Microglobulin and Plasma Proteins from an Agrarian Indian Community By a Door-to-Door Survey: Results of Simple (IMAGe-002B) Study
    • Journal: Blood
    • Year: 2023-11-02
    • DOI: 10.1182/blood-2023-191125
    • Contributors: Yash Vashishth, Uday Yanamandra, Saurabh Bobdey, Vaibhav Sharma, V K Bhatti, J Muthukrishnan, Pankaj Malhotra, Velu Nair
  4. Prevalence of MGUS in Rural Indian Population: Results of Simple (IMAGe-002A) Study
    • Journal: Blood
    • Year: 2023-11-02
    • DOI: 10.1182/blood-2023-189661
    • Contributors: Celine Raphael, Uday Yanamandra, Saurabh Bobdey, Vaibhav Sharma, V K Bhatti, J Muthukrishnan, Pankaj Malhotra, Velu Nair

 

 

Isabella Colonna | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Isabella Colonna | Medicine and Dentistry | Best Researcher Award

MD, PhD at ASL Lecce, Ospedale Ferrari – Casarnao, Italy.

Dr. Isabella Colonna, MD, PhD, is a highly skilled neurologist with a deep specialization in epilepsy. She serves as the head of the EEG/Epilepsy Unit at the Neurology Department of “F. Ferrari” Hospital in Casarano, ASL Lecce, Italy. With nine years of experience, Dr. Colonna has significantly contributed to both clinical practice and research in neurology. She has a robust academic background, having earned her medical degree with honors from the University of Rome Tor Vergata, followed by her PhD focusing on neuroimaging in Alzheimer’s Disease. Her involvement with the European Academy of Neurology (EAN) as a representative on the Communication Committee and her role as an EAN Brain Health Ambassador underscore her commitment to advancing neurological health awareness across Europe. Dr. Colonna’s work in promoting brain health and collaboration between neurological societies, political institutions, and patient organizations is widely recognized, positioning her as a leader in the field.

Professional Profile

Education

Dr. Isabella Colonna graduated cum laude in Medicine from the University of Rome Tor Vergata in 2014, achieving a score of 110/110. She further expanded her education through an Erasmus program at the Medical University of Regensburg, Germany, in 2012-2013. After obtaining her medical degree, she pursued a residency in Neurology at the Medical University of Graz, Austria, which she completed in 2021. During her residency, she engaged in clinical training and research, culminating in a PhD with a focus on “Magnetization Transfer Imaging: A Non-Conventional MRI Technique for Longitudinal Assessment of Alzheimer’s Disease.” Recognized for her expertise, Dr. Colonna also earned a Neurosonology Certification from the General Medical Council of Austria in 2021. Additionally, she completed a Master’s degree in Neurophysiology at the Medical University of Bologna from 2023 to 2024, which further strengthened her skills in the field.

Professional Experience

Dr. Isabella Colonna’s professional journey reflects her dedication to clinical neurology and research. Since 2023, she has been leading the EEG/Epilepsy Unit at the “F. Ferrari” Hospital in Casarano, ASL Lecce, Italy. Prior to this role, she served as a neurologist in various hospitals across Southern Italy, including the “A. Perrino” Hospital in Brindisi and the IRCCS Maugeri di Bari, where she gained extensive experience in treating neurological disorders. From 2015 to 2021, Dr. Colonna was a neurology resident at the Medical University of Graz, Austria, where she honed her skills in neuroimaging and patient care. During this time, she also served as a teaching assistant at the university, sharing her knowledge with students. Her professional experience extends to her involvement with the European Academy of Neurology (EAN), where she has played a key role in communication efforts and advocacy for brain health.

Research Interest

Dr. Isabella Colonna’s research interests are centered on advancing the understanding of neurological disorders, particularly through neuroimaging and epilepsy research. Her PhD research focused on “Magnetization Transfer Imaging” as a method for tracking changes in Alzheimer’s disease over time, highlighting her interest in non-conventional MRI techniques. Her work aims to improve the diagnosis and management of Alzheimer’s and other neurodegenerative conditions through advanced imaging methods. Additionally, she is passionate about improving patient outcomes in epilepsy, which aligns with her current role as the head of the EEG/Epilepsy Unit at “F. Ferrari” Hospital. Dr. Colonna is also deeply committed to brain health awareness and policy-making, as evidenced by her involvement in the European Academy of Neurology’s (EAN) initiatives. Her research contributions, such as a recent study on the role of neurological societies in promoting brain health in Europe, underscore her dedication to bridging clinical practice with innovative research.

Research Skills

Dr. Isabella Colonna possesses a diverse set of research skills that have contributed to her success in the field of neurology. She is proficient in advanced neuroimaging techniques, including Magnetization Transfer Imaging (MTI), which she utilized during her PhD research to study Alzheimer’s disease progression. Her expertise extends to neurophysiology, as evidenced by her leadership of the EEG/Epilepsy Unit at “F. Ferrari” Hospital, where she applies her skills in electroencephalography (EEG) for the diagnosis and management of epilepsy. Dr. Colonna is also experienced in conducting clinical research, having completed multiple projects that have led to publications in reputable journals. Her work with the European Academy of Neurology (EAN) has further developed her skills in survey-based research, focusing on brain health awareness. Additionally, she has experience as a reviewer and abstract evaluator for the EAN, contributing her expertise to the advancement of neurological research.

Awards and Honors

Throughout her career, Dr. Isabella Colonna has received numerous awards and honors, reflecting her outstanding contributions to the field of neurology. In 2019, she was awarded the “Young Investigator Award” by the Austrian Alzheimer Association (Österreichische Alzheimer Gesellschaft) for her research on neuroimaging in Alzheimer’s disease. The same year, she received a bursary from the European Academy of Neurology (EAN) for her participation in the 5th EAN Congress in Oslo, Norway. Dr. Colonna’s commitment to advancing brain health awareness was further recognized in 2024, when she was named an EAN “Brain Health Ambassador.” Her involvement with the EAN also includes roles as a representative on the eCommunication Board and Communication Committee, where she has contributed to shaping the dialogue around neurological health. These accolades highlight her leadership, expertise, and dedication to improving neurological care and research on both national and European levels.

Conclusion

Isabella Colonna is a strong candidate for the Best Researcher Award. Her contributions to neurology, particularly in neuroimaging and epilepsy, her active involvement in professional societies, and her research accomplishments make her well-suited for this recognition. Strengthening her international collaborations and focusing on innovation could further bolster her profile for such prestigious awards.

Publications Top Notes

  1. Cortical laminar necrosis due to hypoglycemia in anti-CV2/CRMP5 paraneoplastic encephalitis: a curious association
    • Authors: Altomare, S., Colonna, I., Leone, R., Giorelli, M.
    • Year: 2024
    • Citations: 0
    • Journal: Acta Neurologica Belgica, 124(4), pp. 1405–1408.
  2. Sex steroid hormones and epilepsy: Effects of hormonal replacement therapy on seizure frequency of postmenopausal women with epilepsy—A systematic review
    • Authors: Carvalho, V., Colonna, I., Curia, G., Vonck, K., Zedde, M.
    • Year: 2023
    • Citations: 2
    • Journal: European Journal of Neurology, 30(9), pp. 2884–2898.
  3. Bringing door-to-needle times within the European benchmarks results in better stroke patients outcomes in a spoke hospital from the Apulian Region
    • Authors: Giorelli, M., Leone, R., Aniello, M.S., Tatò, E., Scelzi, A.
    • Year: 2023
    • Citations: 1
    • Journal: Neurological Sciences, 44(9), pp. 3199–3207.
  4. Serum levels of IL-6 are associated with cognitive impairment in the salus in apulia population-based study
    • Authors: Griseta, C., Battista, P., Castellana, F., Minafra, B., Sardone, R.
    • Year: 2023
    • Citations: 6
    • Journal: Heliyon, 9(3), e13972.
  5. Clinico-genetic spectrum of limb-girdle muscular weakness in Austria: A multicentre cohort study
    • Authors: Krenn, M., Tomschik, M., Wagner, M., Löscher, W.N., Cetin, H.
    • Year: 2022
    • Citations: 4
    • Journal: European Journal of Neurology, 29(6), pp. 1815–1824.
  6. Predicting atrial fibrillation after cryptogenic stroke via a clinical risk score—a prospective observational study
    • Authors: Kneihsl, M., Bisping, E., Scherr, D., Enzinger, C., Gattringer, T.
    • Year: 2022
    • Citations: 22
    • Journal: European Journal of Neurology, 29(1), pp. 149–157.
  7. Microstructural tissue changes in Alzheimer disease brains: Insights from magnetization transfer imaging
    • Authors: Colonna, I., Koini, M., Pirpamer, L., Schmidt, R., Ropele, S.
    • Year: 2021
    • Citations: 6
    • Journal: American Journal of Neuroradiology, 42(4), pp. 688–693.
  8. Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer’s disease patients: a retrospective observational study
    • Authors: Scaricamazza, E., Colonna, I., Sancesario, G.M., Mercuri, N.B., Liguori, C.
    • Year: 2019
    • Citations: 30
    • Journal: Neurological Sciences, 40(7), pp. 1377–1382.
  9. Cognitive Deficits and Related Brain Lesions in Patients With Chronic Heart Failure
    • Authors: Frey, A., Sell, R., Homola, G.A., Störk, S., Stoll, G.
    • Year: 2018
    • Citations: 74
    • Journal: JACC: Heart Failure, 6(7), pp. 583–592.
  10. Abnormal blood flow on transcranial duplex sonography predicts poor outcome after stroke thrombectomy
    • Authors: Kneihsl, M., Niederkorn, K., Deutschmann, H., Fazekas, F., Gattringer, T.
    • Year: 2018
    • Citations: 18
    • Journal: Stroke, 49(11), pp. 2780–2782.